Physician profile
Krishna P Bhat
NPI 1891746012
$30,179.80
in general payments reported to CMS, 2019-2025
44 companies · $3,006 in 2025
The $3,006 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,916 · 2020: $5,038 · 2021: $8,842 · 2022: $4,635 · 2023: $2,694 · 2024: $3,049 · 2025: $3,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,021 · Travel and Lodging: $707 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,020.68 |
| Travel and Lodging | $707.39 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22,360.06 | 2019-2025 | Proclaim, Eterna, Octrode |
| Saluda Medical Americas, INC. | $1,279.94 | 2023-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $1,219.80 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $1,016.23 | 2019-2023 | |
| Abbvie INC. | $634.04 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Si-Bone, INC. | $545.22 | 2020-2025 | |
| Nevro Corp. | $456.04 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $334.97 | 2019-2025 | Relistor |
| Amgen INC. | $248.86 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $242.61 | 2019-2024 | |
| Assertio Therapeutics, INC. | $173.40 | 2019-2020 | |
| Spineart USA INC | $159.53 | 2021 | |
| Sonex Health, INC. | $133.67 | 2022 | |
| Virtus Pharmaceuticals LLC | $124.95 | 2023-2025 | Levorphanol Tartrate |
| Novo Nordisk INC | $120.13 | 2019-2023 | Wegovy |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.